Prehypertension and risk of cardiovascular diseases-Reference-Cited by-同舟云学术

Prehypertension and risk of cardiovascular diseases

Published:2019-12 Issue:12 Volume:37 Page:2325-2332
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Han Minghui,Li Quanman,Liu Leilei,Zhang Dongdong,Ren Yongcheng,Zhao Yang,Liu Dechen,Liu Feiyan,Chen Xu,Cheng Cheng,Guo Chunmei,Zhou Qionggui,Tian Gang,Qie Ranran,Huang Shengbing,Wu Xiaoyan,Liu Yu,Li Honghui,Sun Xizhuo,Zhang Ming,Hu Dongsheng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference53 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.;Lancet,2018

2. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.;Lancet,2018

3. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.;Lancet,2018

4. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report;Chobanian;JAMA,2003

5. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem;Wang;Arch Intern Med,2004

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and rationale for a randomized, open-label, parallel clinical trial evaluating major adverse cardiovascular events (pharmacological treatment versus diet control) in patients with high-normal blood pressure: the PRINT-TAHA9 trial;Trials;2024-08-26

2. Puerarin Alleviates Blood Pressure via Inhibition of ROS/TLR4/NLRP3 Inflammasome Signaling Pathway in the Hypothalamic Paraventricular Nucleus of Salt-Induced Prehypertensive Rats;Nutrients;2024-08-06

3. Modifiable Risk Factors for Stroke, Dementia, and Late-Life Depression: A Systematic Review and DALY Weighted Risk Factors for a Composite Outcome;2024-07-08

4. Design and Rationale for a Randomized, Open-Label, Parallel Clinical Trial Evaluating Major Cardiovascular Events (Pharmacological Treatment Versus Diet Control) in Patients with High-Normal Blood Pressure: The PRINT-TAHA9 Trial;2024-06-12

5. Prospective associations between systolic blood pressure, serum cholesterol, and physical activity behaviour and the development of cardiovascular disease;Preventive Medicine;2024-06